Bioinformatics and in vitro studies have revealed that single-stranded circular RNAs (circRNAs), generated through 'backsplicing,' occur more extensively than initially appreciated. While the functions of most circRNAs are unknown, binding of microRNAs (miRNA), regulation of splicing and transcription, and translation into proteins have all been demonstrated for specific circRNAs.
Introduction
Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that infect stratified epithelia. While the majority of HPV infections are asymptomatic or cause benign warty growths, a subset of 'high-risk' HPVs can promote the development of cervical, oropharyngeal, anal, vulvovaginal, and penile cancers. The recognition of the critical role of HPV infection in the pathogenesis of ~5% of human cancers has spurred the development of vaccines that have the potential to decrease the burden HPV-driven malignancies 1 . Despite this progress, our understanding of how high-risk HPVs progress from latent infections to incurable cancers remains incomplete.
One strategy employed by HPV to regulate its life cycle is through alternative splicing of its relatively small number of transcripts 2 . In particular, extensive splicing of the early region of high-risk HPV appears to be critical for its tumorigenic properties. The E6 and E7 oncoproteins are transcribed on a bicistronic mRNA, and most E7 oncoprotein translation occurs from a truncated E6 transcript (E6*I) through a mechanism involving translation reinitiation 3, 4 . However, mutations abolishing the 5' splice donor in the E6 intron do not completely abolish E7 oncoprotein expression suggesting that alternative, uncharacterized transcripts might also contribute to E7 translation 4, 5 . In addition to splicing, many viruses employ non-coding RNAs to promote fitness. Non-coding RNAs, like adenovirus VA and Epstein-Barr Virus (EBV) EBER, prevent the activation of innate immune responses 6 . Similarly, miRNA, like those encoded by EBV and the SV40 polyomavirus, have also been shown to limit activation of the host immune response through targeting of both host and viral targets 7, 8 .
The occurrence of covalently closed single-stranded RNAs (circRNAs) was initially thought to be limited to viroids and rare splicing events from uncommon loci 9 . However, with the recent realization that circRNAs are abundant, interest in this class of RNA molecules has increased. The best characterized circRNAs function as microRNA sponges. For example, circHIPK3, a circRNA derived from the second exon of HIPK3, binds multiple miRNAs, including miR-124, to promote the growth of cancer cells in vitro 10 . However, recent studies have suggested additional roles for circRNAs, including the ability of some circRNAs to encode for proteins. Because the translation of circRNAs appears to be markedly lower than that of 5', 7methylguanosine capped and polyadenylated transcripts, the biological relevance of circRNAdriven protein production remains unclear. Recent studies have also revealed that EBV and Kaposi Sarcoma Virus (KSHV) generate a diverse menagerie of circRNA 11, 12 . The functions of these viral circRNAs remain uncertain.
We report the discovery of circRNAs from high-risk HPV. Characterization of the abundant HPV16 circE7 revealed that it can be translated through cap-independent mechanisms. HPV-derived circE7 is abundant in cervical and head and neck cancers in The Cancer Genome Atlas (TCGA), and HPV16 circE7 is essential for the transformed growth of CaSki cervical carcinoma cells.
Results
To screen for the presence of circRNA in HPV, we developed a pipeline to detect and visualize backsplice junctions from viral genomes (vircircRNA).
To ensure accurate identification of all backsplices, circular viral genomes were concatenated and then utilized as the reference genome for the pipeline (Fig. S1a-b ). We selected ten HPV subtypes ( Fig. S1c) as reference genomes to screen against publicly deposited RNA-seq datasets (Fig. S1d ). We identified 12 projects with RNA-seq data from HPV-infected tissues. Despite the fact that most samples were not optimized for circular RNA sequencing through RNase R treatment or ribosomal RNA depletion, we identified 27 samples with multiple reads mapping to putative backsplice junctions ( Fig. S1d) . In our initial screen, backsplice reads were identified from HPV16 and HPV35 ( Fig. 1a , S1e). Specific HPV16 circRNAs were notable because their abundance was comparable to spliced linear mRNAs ( Fig. 1a-b ). The majority of backsplice reads (>93% of total HPV reads, 72% of HPV16-or HPV35-positive samples) were generated from the head to tail joining of established linear splice sites downstream in E1 (nt 16) to one upstream in E6 (nt 7451) ( Fig. 1a -c, S1e). This backsplicing is predicted to form a 472nt circular RNA, which contains the entire open reading frame of E7 ( Fig. 1c ). Due to the established importance of the E7 oncogene and the abundance of HPV16 circE7, we focused on this putative circRNA for additional analyses. We tested for the presence of backsplicing by inverse PCR using three cancer cell lines in which HPV16 has been shown to be stably integrated (CaSki and SiHa cervical cancer, UPCI-SCC154 tongue squamous cell cancer). RNase R is an exoribonuclease that specifically degrades linear, but not circular or lariat, RNAs. While a linear region of HPV16 E6/E7 was markedly decreased in abundance after RNase R treatment, the circE7 junction detected in all 3 cell lines before RNase R was enriched after treatment ( Fig. 1d ).
Sanger sequencing of the amplified inverse PCR product from all three cell lines confirmed that the circE7 backsplice represented a true splice site rather than an intron lariat ( Fig. 1e ), which frequently contains untemplated nucleotides across the branch point 13 . HPV16 circE7 could be identified in the cancer cell lines by Northern blot as an RNase R resistant band that migrated more slowly than its predicted size due to its circular structure 14 (Fig. 1f ). Given the prevalence of HPV18 in HPV-induced cancers, we also tested 3 HPV18+ cell lines for the presence of a similar circular RNA (HPV18 circE7) ( Fig. S2a ). However, an analogous HPV18 circE7 could not be detected by either RT-PCR or Northern blot ( Fig. S2b-c) . We cannot exclude that HPV18 circE7 is present in these cells at levels below the sensitivity of these in vitro assays.
CircRNAs have been reported to function by sponging miRNAs 15, 16, 17 . To determine whether circE7 might have a role as a miRNA sponge, we determined whether any miRNA binding sites existed on the transcripts. While both HPV16 HPV35 circE7 were predicted to have miRNA binding sites ( Fig. S3a-b ), none of the predicted miRNA binding sites were conserved between the HPV16 and HPV35 circE7 species 18 . Since circRNAs have the potential to encode peptides, we next tested whether circE7 might be translated. To facilitate the detection of circE7 translation, we generated minigene expression vectors encompassing the entire ~1kb backspliced region of the HPV16 genome ( Fig. 2a ). All constructs were flanked by quaking (QKI) protein binding sites, which facilitate the circularization of RNAs 19 . Some of the constructs contained mutations of the potential start codons (no ATG) and/or a C-terminal 3xFLAG epitope tag to facilitate the detection of E7. Human embryonic kidney cells (HEK293T)
were transfected with the minigenes and assayed for circRNA formation by RT-PCR using divergent primers. We detected RNase R-resistant circRNAs of the expected size from both WT and epitope tagged circE7 ( Fig. 2b ). When HEK293T cells were transfected with the circE7 minigenes, we were able to detect E7 protein using both HPV16 E7-specific and Flag antibodies, but not when the E7 start codons were mutated ( Fig. 2c-d ). To confirm that circular, rather than linear E7 RNAs, were responsible for E7 translation, we designed small interfering RNAs (siRNAs) to target sequences specific to the backsplice junction, the linear mRNA, or a region shared by both linear and circular species ( Fig. 2a ). RT-PCR confirmed that siRNAs against the circE7 backsplice preferentially knocked down the circular transcript; those against linear E6/E7 preferentially depleted the linear transcript; and those targeting E7 knocked down both RNAs ( Fig. S3c ). Notably, knockdown of circE7 or shared regions of the E7 ORF inhibited the expression of E7 protein. In contrast, siRNAs targeting the linear RNA did not strongly decrease E7 expression by Western blot (Fig. 2c ). CircRNAs are predicted to be translated through a cap-independent mechanism, which can be upregulated by cell stressors, including heat shock 20, 21 . 293T cell transfected with wild-type or Flag-tagged circE7 constructs increased E7 translation, >four-fold and >two-fold, respectively, in response to a 42°C heat shock ( Fig. 2d,   S3d ). In contrast, a linear control RNA (Flag-GFP) showed a >two-fold decrease in expression after heat shock ( Fig. 2d, S3d ).
To determine the subcellular localization of circE7, cells were fractionated and nuclear and cytoplasmic fractions confirmed with MALAT1 and 18S or β-actin, respectively. Consistent with the behavior of other translated circRNAs 20, 22, 23, 24 , RT-PCR confirmed that the majority of circE7 (~60%) localized to the cytoplasm ( Fig. 2e ). Northern blots confirmed the cytoplasmic enrichment of circE7 ( Fig. 2f ). Cap-independent translation of circRNAs has been reported to require N 6 -methyladenosine (m 6 A) modifications in the UTR 20 . Because HPV16 circE7 possessed multiple potential m 6 A consensus sites (DRACH) ( Fig. S3d ), we performed m 6 A RNA immunoprecipitation (IP) experiments. Antibodies against m 6 A, but not an IgG control, pulled down circE7 even more efficiently than SON, a control mRNA containing multiple m 6 A sites and previously confirmed to be methylated 20 . We constructed a circE7 mutant in which potential m 6 A motifs in the UTR were mutated (circE7_noDRACH) (Fig. S3e ). Unexpectedly, this construct dramatically decreased the abundance of circE7, but not its linear E6/E7 counterpart ( Fig. S3f ). Mutation of the potential m 6 A motifs also strongly inhibited E7 expression, further confirming the critical role for the circular, rather than the linear, RNA in E7 translation ( Fig. S3g ).
Thus, circE7 is m 6 A-modified, enriched in the cytoplasm, and capable of generating the E7 oncoprotein in a heat shock regulated manner.
The functions of most circRNA remain ambiguous. In particular, the possible functions of virally-encoded circRNAs and those purported to encode for proteins remain particularly poorly characterized. To determine the biological functions of circE7, we specifically depleted circE7 in CaSki cells using two doxycycline-inducible short hairpin RNAs targeting the circE7 backsplice junction (circE7 sh1/2). After lentiviral transduction of the circE7 shRNA-expressing plasmid, we confirmed the specificity of the circE7 shRNA by qRT-PCR. After doxycycline induction, both circE7 shRNA resulted in a significant reduction of the circE7 as assessed both by RT-PCR and Northern blot ( Fig. 3a-b ). Importantly, we did not note a significant reduction of the linear E6/E7 sequences or the previously described E6*I transcript ( Fig. S4a-b ). Unexpectedly, both qRT-PCR and Northern blot suggested that knockdown of circE7 actually caused an increase in linear HPV16 E6/E7 transcripts ( Fig. S4a-b ). Next, we tested whether loss of circE7 would impact levels of E7 protein in CaSki cells. Induction of circE7 shRNA 1/2 decreased levels of endogenous E7 protein by >two-fold ( Fig. 3c , S4c), demonstrating that circE7 is required for optimal E7 expression in CaSki cells. Consistent with E7's established role in transformation, depletion of circE7 resulted in decreased cell proliferation as measured by both cell number and MTT assay ( Fig. 3d ; S4d-e). CaSki cells expressing circE7 shRNA showed significantly decreased entry into S phase as measured by BrdU incorporation (Fig. 3e , S4f) consistent with a critical role for E7 in overriding Rb's function in regulating cell cycle progression 25 . Induction of circE7 sh1/2 also significantly inhibited the ability of CaSki cells to form colonies in soft agar ( Fig. 3f ). We conclude that circE7 is essential for E7 expression and the transformed growth of CaSki cervical carcinoma cells.
Given the critical role of circE7 in maintaining transformation in CaSki cells, we tested whether circE7 might be more broadly relevant in human cancers. We analyzed TCGA RNA-seq data from cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) and
head and neck squamous cell carcinoma (HNSC) using the vircircRNA pipeline and identified more than 100 patient tumors with at least two reads identifying the same HPV backsplice junction. To ensure the specificity of the identified HPV reads, a control analysis of kidney renal clear cell carcinoma (KIRC), which has been reported to be free of HPV transcripts 26 , yielded no HPV sequence reads or backsplice junctions using identical search parameters. Backsplice junctions were detected from multiple high-risk HPV, with HPV16 being the most abundant species (Fig. 3g ). Consistent with our preliminary pipeline analysis, multiple species of circE7
were the most abundant type of backsplice identified in all high-risk HPV species (>95% of total species). In contrast to our in vitro analyses, HPV18+ patient tumors also appeared to possess frequent backsplices consistent with HPV18 circE7.
Discussion
We describe the functional activity of a viral, protein-coding circRNA. 25, 27 . Thus, the low translational activity of circE7, in addition to the established stability of circRNAs relative to linear mRNAs, might make them particularly well-suited to promote the fitness of infected cells during latency. Our studies also implicate m 6 A in the regulation of circE7. While a previous study implicated RNA methylation specifically in circRNA translation 20 , the mutation of the abundant m 6 A-consensus motifs in the UTR of circE7 dramatically decreased the efficiency of backsplicing in our assays. Although m 6 A-motifs do not appear to be essential for splicing 28 , we speculate that m 6 A deposition on the nascent circE7
RNA may somehow coordinately regulate backsplicing and translation. While the m 6 A motif sites do not correspond to the binding sites for factors known to regulate HPV splicing 29 , we have not excluded the possibility that the mutations might also directly impact circE7 backsplicing by altering the binding of canonical splicing factors.
While our studies focused on circE7, we speculate that other viral and protein-coding circRNAs will also ultimately be shown to have biologically relevant properties. The functional activity of circE7 also suggests important avenues for additional investigation. The compact size of circE7 may be useful as a template for understanding how backsplicing is regulated.
Such studies may also yield even novel insights on how HPVs regulate infection, latency, and tumorigenesis. The detection of circE7 may also have clinical implications. Given the stability of circRNA and the importance of the E7 oncoprotein in tumorgenesis, it will be worthwhile determining whether circE7 would be useful as a diagnostic test. While the utility of high-risk
HPV testing for cancer screening is well established, it will be interesting to determine whether the specific presence of the circE7 backsplice junction has any prognostic significance. As technologies to deliver RNAs for therapeutic benefit mature, protein expressing circRNAs, like circE7, may serve as a backbone for the design and optimization of protein-expressing circRNAs.
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Materials and Methods
De novo circular RNA detection from circular viral genomes. To detect and display circular RNA from RNA sequencing (RNA-seq) data of viruses with circular genomes, a custom pipeline named vircircRNA was developed (https://github.com/jiwoongbio/vircircRNA). Because the arbitrary linearization of circular genomes causes confusion in distinguishing between back and forward splices, two genomes were concatenated and used as the reference sequence for read mapping. RNA-seq reads were aligned using Burrows-Wheeler Aligner (BWA, v0.7.15) 1 with specific options, "-T 19" to reduce minimum score to output and "-Y" to use soft clipping for supplementary alignments. Reads mapped to different positions with soft clipping were extracted as candidate segmented reads by splicing. Canonical GT-AG splice donor-acceptor motifs were used to exclude non-splice reads and define splice breakpoints. Information on strand specificity of sequencing and annotation of genes and promoters were included if available. Splice reads mapped in chiastic order were defined as back-splice reads from circular RNAs. The back-splice junction ratio was calculated by employing the equation:
are the numbers of back-splice, 5' and 3' normal-splice junction reads.
Circular RNA detection from public and TCGA RNA-seq data. For selected HPV, the genome sequences and the annotations were downloaded from National Center for Biotechnology Information (NCBI) nucleotide database. We used the keywords of "HPV" and "human papillomavirus" to search public sequencing data of HPV from NCBI Sequence Read Archive Percentages of m6A modified RNA for both circE7 were calculated based on the input reading.
Doxycycline inducible shRNA Construct and Lentiviral packaging. Short hairpin RNA (shRNA) sequences specifically targeting circE7 back-splice junction were designed from Invitrogen BLOCK-ItTM RNAi Designer (https://rnaidesigner.thermofisher.com/rnaiexpress/). Forward and reverse oligos were annealed in NEB buffer 2, and then phosphorylated and ligated into EZ-Tet-pLKO-Blasticidin vector 4 (Addgene #85973) using NheI/EcoRI. To package lentiviruses, LentiX-293T cells were plated at ~70%-80% confluence 12-16hrs before transfection. Transfer plasmid, pMD2.G and psPAX2 were then co-transfected into LentiX-293T cells by Lipofectamine 3000 at molar ratio of 1:1:1. Viruses were harvested at 48hr and 72hr post-transfection. For lentiviral transduction, CaSki cells were plated into 6 well plate at 50% confluence without any antibiotics.
Viral supernatant was then added to the cell in presence of polybrene at final concentration of 8µg/mL. 48hrs after transduction, the cells were then exposed to blasticidin selection at final concentration of 10µg/mL for the first day and then increased to 15µg/mL on the second day of selection. Cells were selected for ≥ 7days before the antibiotic concentration was decreased to 5µg/mL for maintenance of stable cell lines. For shRNA expression induction, doxycycline was added to culture medium at final concentration of 1µg/mL for at least three consecutive days and cells were then subjected to analyses.
Cell proliferation and MTT cell growth assay. For the cell proliferation assay, 60,000 CaSki cells were plated on Day 0 in quadruplicate RPMI with 10%FBS (doxycycline free) with or without 1µg/mL doxycycline. Cells were counted daily after Day 2. For MTT based cell growth rate analysis, 1000 CaSki cells stably transduced with two shRNA constructs were plated into each well of 96 well plates in triplicates for at least 8 days without doxycycline. The first time point was done 24hrs after plating, serving as a reference point. After 24 hrs, doxycycline was added to the rest of plates. The MTT assay was performed daily for 7 days. All the readings from the same well were normalized by the reference point. MTT (Invitrogen#M6494) reactions were performed as recommended by manufacturer.
BrdU Incorporation Assay. CaSki cells stably transduced with circE7 shRNA1/2 were induced by 1µg/mL doxycycline for at least three days. Control cells (no dox) and induced cells were then plated into Nunc 4-well chamber slides (ThermoFisher 154453) in triplicate. Cells were labeled with 10µM BrdU for 1.5hrs. Cells were then fixed by 4% paraformaldehyde at RT for 10mins,
